pg 396 of 471 select investigation pp and affiliated orgs

investigation headed by Rep Marsha Blackburn (R - Tn) 2016

Quality control is similarly not the province of the abortion clinic. The remains of

an unborn child are caught in a nominally sterile pan. A tissue technician sorts

through the remains and harvests the tissue for which she has customer orders. In

virtually all cases, the tissue is packaged immediately for shipping. This work is

usually performed in a clinic pathology lab which exists to make sure all body

parts are removed from the mother’s uterus and then the remains are stored for

disposal. There is no quality control performed by the abortion clinic at this point

in the fetal tissue procurement process. Quality control refers instead to the

downstream effort by the researcher to assure the purity and integrity of their

specimen, anticipated at the time of passage of § 289g to be transplant into a

human subject.

https://archives-energycommerce.house.gov/sites/republicans.energycommerce.house.gov/files/documents/Select_Investigative_Panel_Final_Report.pdf

Human fetal tissue is currently used by a very small number of scientists, representing

less than 0.2% of the total NIH research portfolio. Detailed analysis of how human fetal tissue is

used in 34 long-standing, successful research programs has determined that fetal tissue is

actually required for only approximately 24% of these grants. For the remaining 76%, there are

reasonable alternatives to the use of human fetal tissue and, in the majority of cases, these

alternatives are superior scientific models. Based on these percentages, it is estimated that of the

current 329 NIH-funded grants using human fetal tissue, only approximately 79 (or 0.08% of the

83,592 active projects), actually require the use of human fetal tissue. Thus, despite the repeated

claim that human fetal tissue is “necessary” for modern biomedical research, only a tiny fraction

of NIH funded research actually requires human fetal tissue. Moreover, even in cases where use

of human fetal tissue is warranted (i.e., Class 1 grants), this analysis indicates that human fetal

tissue research is less productive and has lower impact on the field, compared to studies

from the same laboratories that do not involve human fetal tissue.

In Conclusion: This analysis strongly indicates that, in contrast to repeated assertions,

human fetal tissue research is an outdated and unproductive area of research that does not make a strong impact on the field. In over 100 years of unrestricted investigation, human fetal tissue research has had ample time to prove useful, yet it has failed to do so:

 Fetal tissue HAS NOT produced a single medical treatment.

 Fetal tissue WAS NOT used to cure polio, mumps, and measles.

 Fetal tissue IS NOT used for modern vaccine production or research.

 Fetal tissue IS NOT critical to study Zika or other diseases affecting brain development.

 Fetal tissue IS NOT required for the overwhelming majority of current research.

 Fetal tissue research is LESS PRODUCTIVE and has LOWER IMPACT when compared to non-fetal tissue research.

pg 458

https://archives-energycommerce.house.gov/sites/republicans.energycommerce.house.gov/files/documents/Select_Investigative_Panel_Final_Report.pdf

>>5119352

I do not know what they want them for - scanning through that almost 500 pg investigation. it seems that were doing things improperly against the Belmont principles, without proper documentation and consent. I think the medicare fraud we see on Justice.gov could be related but it is much to late to dig into that for me.

Reading the Texas dr's (office staff testimony) delivering babies, slicing throats with forceps and snipping spinal cord was heart wrenching.